Eisai Presents New Findings for Antibody Drug Conjugate Farletuzumab Ecteribulin at 2022 ASCO Annual Meeting Jun 06, 2022 14:05 HKT/SGT Read More
EC Healthcare Forms a Joint Venture with KaiLong and Asia Allied Infrastructure Jun 06, 2022 10:35 HKT/SGT Read More
CUHK Professor Elaine Chow Receives "2022 Women's Interprofessional Network of the American Diabetes Association Abstract Award" for Outstanding Research and Care in Diabetes Jun 05, 2022 09:07 HKT/SGT Read More
Eisai to Present Latest Data on Lemborexant at The 36th Annual Sleep 2022 Meeting Jun 03, 2022 15:37 HKT/SGT Read More
Boehringer Ingelheim Enters Global Licensing Agreement to Develop and Commercialize Innovative Antibodies from A*STAR for Targeted Cancer Therapies Jun 02, 2022 21:00 HKT/SGT Read More
Boehringer Ingelheim Enters Global Licensing Agreement to Develop and Commercialize Innovative Antibodies from A*STAR for Targeted Cancer Therapies Jun 02, 2022 21:00 HKT/SGT Read More
Novotech Sponsors Pre-ASCO China Summit Panels on Early Phase Oncology Trials, Regulatory Strategy for China and US Jun 02, 2022 18:00 HKT/SGT Read More
Sirnaomics Launches Phase I Clinical Trial of RNAi Therapeutic STP705 in Adults Undergoing Abdominoplasty for Medical Cosmetology Treatment May 30, 2022 15:38 HKT/SGT Read More
Eisai Contributes to the Science of Cancer Medicine at ASCO 2022 May 27, 2022 11:49 HKT/SGT Read More
エーザイ、メコバラミンの高用量製剤がALSの病態及び機能障害の進行抑制を予定される効能又は効果として、厚生労働省より希少疾病用医薬品に指定 May 27, 2022 10:00 JST Read More
The APCO Bone Health QI Tool Kit - Putting a brake on fractures in the world's most populous & fastest ageing region May 24, 2022 08:21 HKT/SGT Read More